The Laboratory for Biomolecular Mass Spectrometry’s (LBMS) mission is to provide the UW campus community with access to cutting-edge small molecule identification and quantification technologies.
About CaMetab
CaMetab is a developing core which will operate within LBMS, a collaborative campus resource founded in 2016 with joint support from the University of Wisconsin and the Morgridge Institute for Research. LBMS is directed by Dr. Josh Coon, and is ably managed by Dr. Katie Overmyer, an expert in use of mass spectrometry in metabolomics.
Contact Us
Director: Josh Coon
Facility Manager: Katie Overmyer
Acknowledgments
Any published research which received funding from the UWCCC Cancer Center Support Grant (CCSG), including the use of UWCCC Shared Resources to generate or analyze data or conduct clinical trials, must reference the UWCCC. See Acknowledging UWCCC in Publications, Posters, and Presentations.